Insights - BIO

Areas of Work

	BIO Issues Call for Applications to Present at Fourth Annual Mid-America VentureForum May 30 2006 Annual Event Provides Opportunity for Fund-Seeking Biotechnology Companies to Present Business Plans Before Hundreds of Venture Capitalists WASHINGTON, D.C. (May 30, 2006) -- The...
	World Congress Will Showcase Industrial Biotechnology for Ethanol, Chemicals, and Consumer Goods May 24 2006 WASHINGTON, D.C. (May 24, 2006) -- The latest advances in industrial biotechnology for renewable fuel and sustainable consumer products made from agricultural feedstocks will be on display at...
	BIO Names Tom DiLenge as General Counsel May 19 2006 WASHINGTON, D.C. (May 19, 2006) -- Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), today named Tom DiLenge as Vice President and General Counsel. ...
	BIO Encouraged by SEC's Plans for Sarbanes-Oxley Reforms May 18 2006 WASHINGTON, D.C. (May 19, 2006) -- Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), issued the following statement in response to the Securities and Exchange...
	BIO Applauds DeMint and Feeney for Their Leadership in Introducing the COMPETE Act May 17 2006 WASHINGTON, D.C. (May 17, 2006) -- Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), joined a press conference on Capitol Hill today at which Senator Jim...
	Media Registration Available Online for BIO VentureForum East 2006 May 16 2006 WASHINGTON, D.C. (May 16, 2006) -- Advance media registration is now available online for the Biotechnology Industry Organization’s (BIO) VentureForum East 2006, scheduled for June 12-14 at...
	Biotechnology Breakthroughs Can Help Drivers Reduce Fuel Costs May 9 2006 WASHINGTON, D.C. (May 9, 2006) -- The U.S. Department of Energy last week reported that gasoline prices had topped $3.00 per gallon in some regions of the United States. Reacting to the...
	Cell Genesys CEO to Represent BIO at SEC Panel on Sarbanes-Oxley Section 404 Reform May 9 2006 WASHINGTON, D.C. (May 9, 2006) -- Stephen A. Sherwin, M.D., Chairman and Chief Executive Officer of Cell Genesys, Inc., will represent the Biotechnology Industry Organization (BIO) tomorrow in...
	GAO Report Finds that Sarbanes-Oxley Section 404 Compliance Costs are Disproportionately Higher for Smaller Companies May 9 2006 WASHINGTON, D.C. (May 9, 2006) – The Government Accountability Office (GAO) released a report yesterday on the effect of the Sarbanes-Oxley Act’s Section 404 on small companies. The report...
	Proposed Changes to Patent Rules Would Harm Biotechnology Companies May 3 2006 WASHINGTON, D.C. (May 3, 2006) – In January, the U.S. Patent and Trademark Office (PTO) proposed changes to patent rules that would restrict the number of claims examined in a single...